<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Antibodies against hepatitis C virus among blood donors at a private hospital in Cebu</title>
  </titleInfo>
  <name type="personal">
    <namePart>Estalilia, Oscar Cinco</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <originInfo>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
  </physicalDescription>
  <abstract>Serum samples from a total of 2,852 blood donors were screened for antibodies against the Hepatitis C virus using a second generation recombinant enzyme linked immunosorbent assay in commercially prepared test kits as part of a study to determine the prevalence rate of anti-HCV among blood donors at the Cebu Doctors Hospital. 316 out of 2,852 (11.08%) blood specimens were positive for anti-HCV antibodies. 166 out of the 316 (52.53%) anti-HCV positive blood specimens had optical density absorbance cutoff values greater than 2,000 indicating a higher infectious potential. 189 out of 1,629 (11.6%) professional blood donors were anti-HCV positive. This was slightly higher when compared to 127 out of 1,223 (10.38%) anti-HCV positive volunteer blood donors. However, this was not statistically significant With the absence of other preventive measures such as active immunizations at the present time, screening for anti-HCV in all blood donors is strongly recommended to diminish the transmission of the Hepatitis C Virus through blood transfusion.</abstract>
  <note type="statement of responsibility">Oscar Cinco Estalilia</note>
  <note>Cebu Doctors' Proceedings, 1992 8 (2) pages 105-112</note>
  <subject authority="mesh">
    <topic>Hepacivirus</topic>
  </subject>
  <subject authority="mesh">
    <topic>Antibodies</topic>
  </subject>
  <subject authority="mesh">
    <topic>Blood Donors</topic>
  </subject>
  <subject>
    <topic>Hepatitis C virus</topic>
  </subject>
  <recordInfo>
    <recordCreationDate encoding="marc">210324</recordCreationDate>
    <recordChangeDate encoding="iso8601">20210324134116.0</recordChangeDate>
    <recordIdentifier source="DOH">D0001J000310</recordIdentifier>
  </recordInfo>
</mods>
